Shaanxi Meibang Pharmaceutical Group Co Ltd (605033) - Total Assets
Based on the latest financial reports, Shaanxi Meibang Pharmaceutical Group Co Ltd (605033) holds total assets worth CN¥1.91 Billion CNY (≈ $278.76 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore how well can Shaanxi Meibang Pharmaceutical Group Co service its debt to assess how comfortably operating cash covers total debt obligations.
Shaanxi Meibang Pharmaceutical Group Co Ltd - Total Assets Trend (2017–2024)
This chart illustrates how Shaanxi Meibang Pharmaceutical Group Co Ltd's total assets have evolved over time, based on quarterly financial data. See shareholders equity of Shaanxi Meibang Pharmaceutical Group Co for net asset value and shareholders' equity analysis.
Shaanxi Meibang Pharmaceutical Group Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Shaanxi Meibang Pharmaceutical Group Co Ltd's total assets of CN¥1.91 Billion consist of 58.9% current assets and 41.1% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 14.4% |
| Accounts Receivable | CN¥79.76 Million | 4.3% |
| Inventory | CN¥264.71 Million | 14.2% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥118.48 Million | 6.4% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2017–2024)
This chart illustrates how Shaanxi Meibang Pharmaceutical Group Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see 605033 stock market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Shaanxi Meibang Pharmaceutical Group Co Ltd's current assets represent 58.9% of total assets in 2024, a decrease from 83.7% in 2017.
- Cash Position: Cash and equivalents constituted 14.4% of total assets in 2024, up from 8.5% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 6.0% of total assets, an increase from 1.0% in 2017.
- Asset Diversification: The largest asset category is inventory at 14.2% of total assets.
Shaanxi Meibang Pharmaceutical Group Co Ltd Competitors by Total Assets
Key competitors of Shaanxi Meibang Pharmaceutical Group Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Lier Chemical Co Ltd
SHE:002258
|
China | CN¥16.78 Billion |
|
Sichuan Meifeng Chemical Industry Co Ltd
SHE:000731
|
China | CN¥5.17 Billion |
|
Biotalys NV
BR:BTLS
|
Belgium | €28.98 Million |
|
Insumos Agroquimicos SA
BA:INAG
|
Argentina | AR$45.35 Billion |
|
Nufarm Ltd
AU:NUF
|
Australia | AU$4.80 Billion |
|
Minbos Resources Ltd
AU:MNB
|
Australia | AU$36.78 Million |
|
RLF Agtech Ltd
AU:RLF
|
Australia | AU$24.62 Million |
|
Highfield Resources Ltd
AU:HFR
|
Australia | AU$167.71 Million |
Shaanxi Meibang Pharmaceutical Group Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.99 | 2.86 | 1.95 |
| Quick Ratio | 1.66 | 2.38 | 1.06 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥524.65 Million | CN¥686.60 Million | CN¥295.43 Million |
Shaanxi Meibang Pharmaceutical Group Co Ltd - Advanced Valuation Insights
This section examines the relationship between Shaanxi Meibang Pharmaceutical Group Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.38 |
| Latest Market Cap to Assets Ratio | 0.19 |
| Asset Growth Rate (YoY) | 10.0% |
| Total Assets | CN¥1.86 Billion |
| Market Capitalization | $360.27 Million USD |
Valuation Analysis
Below Book Valuation: The market values Shaanxi Meibang Pharmaceutical Group Co Ltd's assets below their book value (0.19x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Shaanxi Meibang Pharmaceutical Group Co Ltd's assets grew by 10.0% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Shaanxi Meibang Pharmaceutical Group Co Ltd (2017–2024)
The table below shows the annual total assets of Shaanxi Meibang Pharmaceutical Group Co Ltd from 2017 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥1.86 Billion ≈ $272.47 Million |
+10.05% |
| 2023-12-31 | CN¥1.69 Billion ≈ $247.59 Million |
+8.43% |
| 2022-12-31 | CN¥1.56 Billion ≈ $228.35 Million |
+6.64% |
| 2021-12-31 | CN¥1.46 Billion ≈ $214.14 Million |
+86.21% |
| 2020-12-31 | CN¥785.87 Million ≈ $115.00 Million |
+18.00% |
| 2019-12-31 | CN¥665.97 Million ≈ $97.45 Million |
+13.69% |
| 2018-12-31 | CN¥585.78 Million ≈ $85.72 Million |
+14.94% |
| 2017-12-31 | CN¥509.66 Million ≈ $74.58 Million |
-- |
About Shaanxi Meibang Pharmaceutical Group Co Ltd
Shaanxi Meibang Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research and development, production, sale, and agricultural technology promotion, and service of pesticide products in China and internationally. The company offers pesticides, fungicides, herbicides, plant growth regulators, fertilizers, and microbial fertilizers. It is also involved in sale of agricu… Read more